Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia
A.M. López Martos(Bellvitge University Hospital), Francesc Gudiol(Instituto de Salud Carlos III), G Rufı́(Bellvitge University Hospital), Javier Martínez‐Sanz(Instituto de Salud Carlos III), Miguel Santín(Bellvitge University Hospital), Daniel Podzamczer(Bellvitge University Hospital)
Cited by 38
Related Papers
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006|137
A Randomized Clinical Trial Comparing Nelfinavir Or Nevirapine Associated to Zidovudine/Lamivudine in HIV-Infected Naive Patients (The Combine Study)
|Antiviral Therapy|2002|137
Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study
|Clinical Microbiology and Infection|2020|108
Fecal microbiota transplantation in HIV: A pilot placebo-controlled study
|Nature Communications|2021|94